Closing the Gap: Treating Hypertension in Women
暂无分享,去创建一个
[1] L. Borrell,et al. Social disparities in periodontitis among United States adults 1999-2004. , 2008, Community dentistry and oral epidemiology.
[2] B. Egan,et al. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial , 2008, Journal of hypertension.
[3] A. Pose-Reino,et al. [Should beta-blockers remain first choice in the treatment of primary hypertension?]. , 2007, Medicina clinica.
[4] W. Frishman,et al. Direct Inhibition of Renin as a Cardiovascular Pharmacotherapy: Focus on Aliskiren , 2007, Cardiology in review.
[5] C. Pepine,et al. Influence of Hispanic ethnicity on blood pressure control and cardiovascular outcomes in women with CAD and hypertension: findings from INVEST. , 2007, Journal of women's health.
[6] S. Solomon,et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial , 2007, The Lancet.
[7] S. Blair,et al. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. , 2007, JAMA.
[8] J. Jordan,et al. Direct Renin Inhibition With Aliskiren in Obese Patients With Arterial Hypertension , 2007, Hypertension.
[9] Rowena J Dolor,et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. , 2007, Journal of the American College of Cardiology.
[10] I. Reid,et al. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women , 2007, Osteoporosis International.
[11] A. LaCroix,et al. Prehypertension and Cardiovascular Disease Risk in the Women's Health Initiative , 2007, Circulation.
[12] C. Lau,et al. Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004 , 2007, Hypertension.
[13] J. Manson,et al. Dietary magnesium intake and risk of incident hypertension among middle-aged and older US women in a 10-year follow-up study. , 2006, The American journal of cardiology.
[14] B. Davis,et al. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2006, Archives of internal medicine.
[15] S. Oparil. Women and Hypertension: What Did We Learn from the Women’s Health Initiative? , 2006, Cardiology in review.
[16] W. Vongpatanasin,et al. Estrogen and hypertension , 2006, Current hypertension reports.
[17] J. Laragh,et al. The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) Trial: Outcomes in Patients Receiving Monotherapy , 2006, Hypertension.
[18] G. Bakris,et al. Thiazide Diuretics, Potassium, and the Development of Diabetes: A Quantitative Review , 2006, Hypertension.
[19] F. McAlister,et al. Re-examining the efficacy of β-blockers for the treatment of hypertension: a meta-analysis , 2006, Canadian Medical Association Journal.
[20] L. Raij,et al. Surgical Menopause Increases Salt Sensitivity of Blood Pressure , 2006, Hypertension.
[21] M. Pfeffer,et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. , 2006, Journal of the American College of Cardiology.
[22] M. Pfeffer,et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. , 2006, Circulation.
[23] B. Levine,et al. Hypertension and antihypertensive therapy in elderly women: how much do we really know? , 2006, Hypertension.
[24] L. Newby,et al. Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials. , 2005, American heart journal.
[25] W. Willett,et al. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort , 2005, BMJ : British Medical Journal.
[26] A. Mitchell,et al. [Women and hypertension]. , 2005, Herz.
[27] D. Lloyd‐Jones,et al. Hypertension in adults across the age spectrum: current outcomes and control in the community. , 2005, JAMA.
[28] S. Oparil,et al. Gender and Blood Pressure , 2005, Journal of clinical hypertension.
[29] E. Rimm,et al. Folate intake and the risk of incident hypertension among US women. , 2005, JAMA.
[30] B. Psaty,et al. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. , 2004, JAMA.
[31] S. Kjeldsen,et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The value randomised trial☆ , 2004 .
[32] T. Lumley,et al. Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based low-dose diuretic therapies. , 2004, JAMA.
[33] J. Laragh,et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial , 2004, The Lancet.
[34] G. Bakris,et al. Differential effects of calcium antagonist subclasses on markers of nephropathy progression. , 2004, Kidney international.
[35] J. Bella,et al. Sex-related difference in regression of left ventricular hypertrophy with antihypertensive treatment: the LIFE study , 2004, Journal of Human Hypertension.
[36] Constance K Haan,et al. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[37] S. Oparil,et al. Essential hypertension in women , 2004, Blood pressure.
[38] Carl J Pepine,et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. , 2003, JAMA.
[39] Thomas Lumley,et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. , 2003, JAMA.
[40] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[41] S. Port. Age-specific relevance of usual blood pressure to vascular mortality , 2003, The Lancet.
[42] E. Schiffrin,et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. , 2003, Archives of internal medicine.
[43] Tosha B. Wetterneck,et al. Prescribing Oral Contraceptives for Women Older Than 35 Years of Age , 2003, Annals of Internal Medicine.
[44] B. Davis,et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.
[45] R. Collins,et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.
[46] J. Murabito,et al. Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study , 2002, Circulation.
[47] Carl J Pepine,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.
[48] Sudha Seshadri,et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.
[49] A. Gavazzi,et al. [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[50] Jiang He,et al. Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2001, Hypertension.
[51] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[52] B. Brenner,et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.
[53] J. Fleg,et al. Hormone Replacement Therapy and Longitudinal Changes in Blood Pressure in Postmenopausal Women , 2001, Annals of Internal Medicine.
[54] D. DeMets,et al. Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.
[55] H. Dargie,et al. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.
[56] J F Reckelhoff,et al. Gender Differences in the Regulation of Blood Pressure , 2001, Hypertension.
[57] M E Safar,et al. Comparative effects of aging in men and women on the properties of the arterial tree. , 2001, Journal of the American College of Cardiology.
[58] J. Williamson,et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials , 2000, The Lancet.
[59] B Neal,et al. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials , 2000, The Lancet.
[60] J. Manson,et al. Hypertension and Its Treatment in Postmenopausal Women: Baseline Data from the Women’s Health Initiative , 2000, Hypertension.
[61] F Gueyffier,et al. Pharmacotherapy for hypertension in women of different races. , 2000, The Cochrane database of systematic reviews.
[62] A. Chobanian,et al. National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure : a critical review of current scientific evidence. , 2000, Hypertension.
[63] P. Whelton,et al. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. , 2000, Hypertension.
[64] P. Whelton,et al. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. , 2000, Hypertension.
[65] K. Kerlikowske,et al. Efficacy of treating hypertension in women , 1999, Journal of General Internal Medicine.
[66] M. Moser,et al. Why are physicians not prescribing diuretics more frequently in the management of hypertension? , 1998, JAMA.
[67] J. Polónia,et al. Low‐dose oral contraceptives and 24‐hour ambulatory blood pressure , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[68] N. Poulter,et al. Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994 , 1997, Journal of hypertension.
[69] J. Cutler,et al. Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men , 1997, Annals of Internal Medicine.
[70] M. Alderman,et al. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients , 1997, The Lancet.
[71] J. Manson,et al. Prospective study of oral contraceptives and hypertension among women in the United States. , 1996, Circulation.
[72] M. Elstein,et al. Low dose combined oral contraceptives , 1995, British journal of obstetrics and gynaecology.
[73] B. Stricker,et al. Angiotensin converting enzyme inhibitor associated cough: a population-based case-control study. , 1995, Journal of clinical epidemiology.
[74] D. Sackett,et al. The number needed to treat: a clinically useful measure of treatment effect , 1995 .
[75] Susan R. Johnson,et al. Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial , 1995 .
[76] L. Wilkins. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. , 1994, Circulation.
[77] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.
[78] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .
[79] M. Alderman,et al. Blood Pressure Management: Individualized Treatment Based on Absolute Risk and the Potential for Benefit , 1993, Annals of Internal Medicine.
[80] P Barham,et al. Management of raised blood pressure in New Zealand: a discussion document. , 1993, BMJ.
[81] A. Sedman,et al. Angiotensin-converting enzyme inhibitor fetopathy. , 1993, Journal of the American Society of Nephrology : JASN.
[82] B. Pitt,et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions , 1992, The Lancet.
[83] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[84] D. Felson,et al. Thiazide diuretics and the risk of hip fracture. Results from the Framingham Study. , 1991, JAMA.
[85] G. Lamas,et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. , 1988, The New England journal of medicine.
[86] K. Silberbauer,et al. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide. , 1982, British journal of clinical pharmacology.
[87] A. Helgeland. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. , 1980, The American journal of medicine.
[88] K. Kushima. [Hypertension in women]. , 1966, Saishin igaku. Modern medicine.
[89] S. Oparil,et al. Health Outcomes Associated with Calcium Antagonists , 2001, Current hypertension reports.
[90] O. Jolobe. Angiotensin-converting enzyme inhibitors. , 1995, British journal of hospital medicine.
[91] A Fournier,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.
[92] W. Willett,et al. A prospective study of nutritional factors and hypertension among US women. , 1989, Circulation.
[93] K. Swedberg,et al. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.
[94] A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. , 1982, JAMA.
[95] Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. , 1967, JAMA.